[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Medicine, Nuclear Medicine, Radiology +15

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

M. de Jong, W A Breeman, WH Bakker et al. · PubMed · 1998 · 210 citations

Medicine, Nuclear Medicine, Pharmacology +15

Biokinetics and dosimetry in patients administered with 111 In-DOTA-Tyr 3 -octreotide: implications for internal radiotherapy with 90 Y-DOTATOC

Marta Cremonesi, Mahila Ferrari, Stefania Zoboli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 151 citations

Medicine, Nuclear Medicine, Pharmacokinetics +14

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

PJ Hammond, A. F. Wade, M E Gwilliam et al. · British Journal of Cancer · 1993 · 132 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.

Marion de Jong, Edgar J. Rolleman, Bert F. Bernard et al. · PubMed · 1996 · 123 citations

Medicine, Nuclear Medicine, Pharmacokinetics +16